Literature DB >> 20309512

[A rare case of a sclerodermoid chronic graft versus host disease. Successful treatment with extracorporeal photopheresis (ECP)].

A G Jung1, H P Bertsch, M P Schoen, U Lippert.   

Abstract

A 31-year-old woman presented with progressive deep linear induration on her lower abdomen, forearms and thighs. These symptoms developed three years after allogenic stem cell transplantation. Furthermore, the patient showed multiple hypopigmented lichenoid papules on the extensor surfaces of the forearms consistent with lichen sclerosus. Histological analysis of a biopsy specimen from her left thigh showed dermal sclerosis extending into the fascia, thus establishing the diagnosis of a rare combination of superficial and deep sclerodermoid chronic graft-versus-host disease. After 7 cycles of extracorporeal photopheresis, a marked resolution of the indurations and a reduction of the modified Rodnan skin score from 12 to 7 were noted.

Entities:  

Mesh:

Year:  2010        PMID: 20309512     DOI: 10.1007/s00105-010-1924-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  22 in total

1.  Lichen sclerosus et atrophicus in sclerodermatous chronic graft-versus-host disease.

Authors:  S Córdoba; E Vargas; J Fraga; M Aragüés; J Fernández-Herrera; A García-Díez
Journal:  Int J Dermatol       Date:  1999-09       Impact factor: 2.736

2.  Chronic cutaneous graft-versus-host disease in man.

Authors:  H M Shulman; G E Sale; K G Lerner; E A Barker; P L Weiden; K Sullivan; B Gallucci; E D Thomas; R Storb
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

3.  Hydroxychloroquine for the treatment of chronic graft-versus-host disease.

Authors:  A L Gilman; K W Chan; A Mogul; C Morris; F D Goldman; M Boyer; E Cirenza; A Mazumder; E Gehan; R Cahill; S Frankel; K Schultz
Journal:  Biol Blood Marrow Transplant       Date:  2000       Impact factor: 5.742

4.  Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum.

Authors:  Julie V Schaffer; Jennifer M McNiff; Stuart Seropian; Dennis L Cooper; Jean L Bolognia
Journal:  J Am Acad Dermatol       Date:  2005-10       Impact factor: 11.527

5.  Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

Authors:  F M Foss; G M DiVenuti; K Chin; K Sprague; H Grodman; A Klein; G Chan; K Stiffler; K B Miller
Journal:  Bone Marrow Transplant       Date:  2005-06       Impact factor: 5.483

6.  Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: report of two cases.

Authors:  Paola L Minciullo; Fortunato Morabito; Rosalba Mandaglio; Pasquale Iacopino; Sebastiano Gangemi
Journal:  Clin Rheumatol       Date:  2005-06-30       Impact factor: 2.980

7.  Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response.

Authors:  Edward D Seaton; Richard M Szydlo; Edward Kanfer; Jane F Apperley; Robin Russell-Jones
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

8.  High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease.

Authors:  R Hesselstrand; A Scheja; M Wildt; A Akesson
Journal:  Rheumatology (Oxford)       Date:  2008-01       Impact factor: 7.580

9.  Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases.

Authors:  O Chosidow; M Bagot; J P Vernant; J C Roujeau; C Cordonnier; M Kuentz; J Wechsler; C André; R Touraine; J Revuz
Journal:  J Am Acad Dermatol       Date:  1992-01       Impact factor: 11.527

10.  U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.

Authors:  J J Scarisbrick; P Taylor; U Holtick; Y Makar; K Douglas; G Berlin; E Juvonen; S Marshall
Journal:  Br J Dermatol       Date:  2008-01-30       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.